Signatur Biosciences
PrivateLast Round
Seed
May 22, 2025
Total Funding Raised
$7.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Signatur Biosciences is a biotechnology company developing a proprietary PCRchitectur platform to make precision diagnostics more accessible and affordable by enabling complex gene expression signature detection on standard qPCR machines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signatur Biosciences Comparables
Compare Signatur Biosciences with similar companies based on industry and business-model similarity.
Signatur Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 22, 2025 | ||||
| Grant | Feb 20, 2025 | ||||
| Seed | Nov 8, 2023 | ||||
| Accelerator | Jul 7, 2022 |
Key People
Founding team and executive leadership
Signatur Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Seed |
| SBRI Healthcare | Grant |
| Y Combinator | Accelerator, Seed |
| Myelin VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 12, 63% of headcount.
- Jul 25, 2026
Monthly visitors grew 917% MoM, from 164 to 1.7K.
Signatur Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Signatur Biosciences's valuation, stock price, and market status.
Is Signatur Biosciences a public or private company?
Signatur Biosciences is a private company.
What is the current stock price of Signatur Biosciences?
Signatur Biosciences is a private company, so its shares have no public market price. Caplight tracks Signatur Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signatur Biosciences worth (valuation)?
Valuation information for Signatur Biosciences is not publicly available.
Can I buy Signatur Biosciences stock?
Signatur Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signatur Biosciences's last funding round?
Signatur Biosciences's most recent funding round was Seed on May 22, 2025.
Who are the main investors in Signatur Biosciences?
Key investors in Signatur Biosciences include Noshaq, SBRI Healthcare, Y Combinator, Myelin VC.
Will Signatur Biosciences IPO soon?
No public IPO plans have been announced for Signatur Biosciences.
How can I track Signatur Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Signatur Biosciences's shares on secondary markets.